Table 1 Effect of pyrazineguanidine and benzoylguanidine compounds on viability of MCF-7 and MDA-MB-231 spheroids.
Structurea | Lipophilicityb | Reported Ki values for NHE1 (µM)c | Reported IC50 values for NHE1 (µM)d | Experimentally determined EC50 values for compound-induced loss of viability (µM)e | ||||
|---|---|---|---|---|---|---|---|---|
MCF-7 | 95% CI | MDA-MB-231 | 95% CI | |||||
Amiloride |
| 0.68 (LogD) 0.93 (LogP) | 1.0–7.0 | 3.7–60 | 30.5 | 18.23–42.28 | 55.8 | 32.51–81.68 |
DMA | 1.64 (LogD) | 0.023–0.5 | 0.19 | 16.6 | 8.47–32.41 | 59 | 30.43–114.20 | |
EIPA |
| 3.2 (LogD) | 0.01–0.1 | 0.016–0.8 | 4.8 | 1.29–17.78 | 19.6* | - |
HMA | 2.94 (LogD) | 0.013 | — | 2.5 | 0.86–7.33 | 13.5 | 4.73–38.34 | |
Cariporide | −1.01 (LogP) | 0.008–0.04 | 0.03–3.4 | ND** | ND | ND** | ND | |
Eniporide |
| −1.03 (LogP) | — | 0.0045–0.38 | ND*** | ND | ND*** | ND |





